Browse > Article
http://dx.doi.org/10.5483/BMBRep.2019.52.2.282

Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells  

Kim, Sang-Min (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine)
Huh, Jae-Wan (Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine)
Kim, Eun-Young (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine)
Shin, Min-Kyung (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine)
Park, Ji-Eun (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine)
Kim, Seong Who (Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine)
Lee, Wooseong (Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine)
Choi, Bongkun (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine)
Chang, Eun-Ju (Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine)
Publication Information
BMB Reports / v.52, no.2, 2019 , pp. 145-150 More about this Journal
Abstract
Endothelial dysfunction-induced lipid retention is an early feature of atherosclerotic lesion formation. Apoptosis of vascular smooth muscle cells (VSMCs) is one of the major modulating factors of atherogenesis, which accelerates atherosclerosis progression by causing plaque destabilization and rupture. However, the mechanism underlying VSMC apoptosis mediated by endothelial dysfunction in relation to atherosclerosis remains elusive. In this study, we reveal differential expression of several genes related to lipid retention and apoptosis, in conjunction with atherosclerosis, by utilizing a genetic mouse model of endothelial nitric oxide synthase (eNOS) deficiency manifesting endothelial dysfunction. Moreover, eNOS deficiency led to the enhanced susceptibility against pro-apoptotic insult in VSMCs. In particular, the expression of aggrecan, a major proteoglycan, was elevated in aortic tissue of eNOS deficient mice compared to wild type mice, and administration of aggrecan induced apoptosis in VSMCs. This suggests that eNOS deficiency may elevate aggrecan expression, which promotes apoptosis in VSMC, thereby contributing to atherosclerosis progression. These results may facilitate the development of novel approaches for improving the diagnosis or treatment of atherosclerosis.
Keywords
Aggrecan; Apoptosis; Atherosclerosis; Endothelial nitric oxide synthase; Vascular smooth muscle cells;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Furchgott RF and Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376   DOI
2 Davignon J and Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109, III27-32
3 Mooradian DL, Hutsell TC and Keefer LK (1995) Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25, 674-678   DOI
4 Ponnuswamy P, Schrottle A, Ostermeier E et al (2012) eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PLoS One 7, e30193   DOI
5 Flammer AJ, Anderson T, Celermajer DS et al (2012) The assessment of endothelial function: from research into clinical practice. Circulation 126, 753-767   DOI
6 Bogaty P, Hackett D, Davies G and Maseri A (1994) Vasoreactivity of the culprit lesion in unstable angina. Circulation 90, 5-11   DOI
7 Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA and Billingham ME (1992) Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90, 1168-1172   DOI
8 Lusis AJ (2000) Atherosclerosis. Nature 407, 233-241   DOI
9 Libby P, Ridker PM and Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325   DOI
10 Clarke MC, Figg N, Maguire JJ et al (2006) Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12, 1075-1080   DOI
11 Klouche M, Peri G, Knabbe C et al (2004) Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 175, 221-228   DOI
12 Zhang MJ, Zhou Y, Chen L et al (2016) Impaired SIRT1 promotes the migration of vascular smooth muscle cell-derived foam cells. Histochem Cell Biol 146, 33-43   DOI
13 Kockx MM and Herman AG (2000) Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45, 736-746   DOI
14 Martinet W and Kockx MM (2001) Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Curr Opin Lipidol 12, 535-541   DOI
15 Martinet W and De Meyer GR (2009) Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res 104, 304-317   DOI
16 Littlewood TD and Bennett MR (2003) Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 14, 469-475   DOI
17 Kuhlencordt PJ, Gyurko R, Han F et al (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104, 448-454   DOI
18 Cao L and Yang BB (1999) Chondrocyte apoptosis induced by aggrecan G1 domain as a result of decreased cell adhesion. Exp Cell Res 246, 527-537   DOI
19 Strom A, Ahlqvist E, Franzen A, Heinegard D and Hultgardh-Nilsson A (2004) Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor deficient mice: an immunohistochemical study. Histol Histopathol 19, 337-347
20 Talusan P, Bedri S, Yang S et al (2005) Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosisresistant human arteries by mass spectrometry. Mol Cell Proteomics 4, 1350-1357   DOI
21 Fujimoto T, Kawashima H, Tanaka T et al (2001) CD44 binds a chondroitin sulfate proteoglycan, aggrecan. Int Immunol 13, 359-366   DOI
22 Gentleman RC, Carey VJ, Bates DM et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5, R80   DOI
23 Didangelos A, Mayr U, Monaco C and Mayr M (2012) Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis. J Biol Chem 287, 19341-19345   DOI
24 Stevens AL, Wheeler CA, Tannenbaum SR and Grodzinsky AJ (2008) Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants. Osteoarthritis Cartilage 16, 489-497   DOI
25 Ross R, Glomset J, Kariya B and Harker L (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71, 1207-1210   DOI